Literature DB >> 11179337

Marrow-derived CD40-positive cells are required for mice to clear Cryptosporidium parvum infection.

A R Hayward1, M Cosyns, M Jones, E M Ponnuraj.   

Abstract

To clear a Cryptosporidium parvum infection, mice need CD4+ T cells, major histocompatibility complex class II, and an intact CD40-CD154 signaling pathway. CD40 is constitutively expressed on marrow-derived cells such as dendritic cells and B lymphocytes and is induced by gamma interferon (IFN-gamma) on most somatic cells. To determine whether the CD40 needed to clear a C. parvum infection has to be on marrow-derived mononuclear cells or on the epithelial cells that normally harbor the parasite, we transplanted CD40-/- mice with CD40+/- bone marrow and then infected them with C. parvum. These chimeras cleared the C. parvum infection, while CD40+/- controls transplanted with CD40-/- marrow cells remained infected. CD40 expression on marrow-derived cells therefore suffices for a C. parvum infection to be cleared, while CD40 expression on intestinal epithelial cells is not sufficient. There was no difference between the acquisition of CD69 and CD154 by mesenteric lymph node T cells of C. parvum-infected animals with intact or disrupted CD40-CD154 pathways. CD4 T cells entered the intestinal laminae propriae of C. parvum-infected animals whether or not the CD40 genes of these recipients were intact. These results suggest that, for a C. parvum infection to be cleared, CD40 is not necessary for T-cell activation but may instead contribute to an effector pathway of marrow-derived cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179337      PMCID: PMC98066          DOI: 10.1128/IAI.69.3.1630-1634.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  A bone marrow-derived APC in the gut-associated lymphoid tissue captures oral antigens and presents them to both CD4+ and CD8+ T cells.

Authors:  E Blanas; G M Davey; F R Carbone; W R Heath
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

Review 2.  Immunobiology of dendritic cells.

Authors:  J Banchereau; F Briere; C Caux; J Davoust; S Lebecque; Y J Liu; B Pulendran; K Palucka
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 3.  Antigen processing and presentation by intestinal epithelial cells - polarity and complexity.

Authors:  R M Hershberg; L F Mayer
Journal:  Immunol Today       Date:  2000-03

4.  IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process.

Authors:  M A Marovich; M A McDowell; E K Thomas; T B Nutman
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

5.  The roles of CD28 and CD40 ligand in T cell activation and tolerance.

Authors:  K C Howland; L J Ausubel; C A London; A K Abbas
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

6.  CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection.

Authors:  J X Gao; J Madrenas; W Zeng; M J Cameron; Z Zhang; J J Wang; R Zhong; D Grant
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

7.  The fate of epithelial cells in the human large intestine.

Authors:  D H Barkla; P R Gibson
Journal:  Pathology       Date:  1999-08       Impact factor: 5.306

8.  Interferon-gamma is required for innate immunity to Cryptosporidium parvum in mice.

Authors:  A R Hayward; K Chmura; M Cosyns
Journal:  J Infect Dis       Date:  2000-08-17       Impact factor: 5.226

9.  Eradication of Cryptosporidium parvum infection by mice with ovalbumin-specific T cells.

Authors:  K Lukin; M Cosyns; T Mitchell; M Saffry; A Hayward
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

10.  Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient mice.

Authors:  E N Villegas; U Wille; L Craig; P S Linsley; D M Rennick; R Peach; C A Hunter
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

View more
  7 in total

1.  CD40 in Endothelial Cells Restricts Neural Tissue Invasion by Toxoplasma gondii.

Authors:  Jose-Andres C Portillo; Jennifer Van Grol; Saad Saffo; Yalitza Lopez Corcino; Myriam Rodriguez; Barbara A Fox; David J Bzik; Nicole L Ward; George R Dubyak; Roxana E Rojas; Zahra Toosi; Carlos S Subauste
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

2.  Cryptosporidium parvum-specific CD4 Th1 cells from sensitized donors responding to both fractionated and recombinant antigenic proteins.

Authors:  Maria Angeles Gomez Morales; Raffaella Mele; Alessandra Ludovisi; Fabrizio Bruschi; Fabio Tosini; Rachele Riganò; Edoardo Pozio
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

Review 3.  CD40 and the immune response to parasitic infections.

Authors:  Carlos S Subauste
Journal:  Semin Immunol       Date:  2009-07-18       Impact factor: 11.130

4.  CD40 induces anti-Toxoplasma gondii activity in nonhematopoietic cells dependent on autophagy proteins.

Authors:  Jennifer Van Grol; Luis Muniz-Feliciano; Jose-Andres C Portillo; Vera L Bonilha; Carlos S Subauste
Journal:  Infect Immun       Date:  2013-03-18       Impact factor: 3.441

5.  Cooperative role of macrophages and neutrophils in host Antiprotozoan resistance in mice acutely infected with Cryptosporidium parvum.

Authors:  Dan Takeuchi; Vickie C Jones; Makiko Kobayashi; Fujio Suzuki
Journal:  Infect Immun       Date:  2008-06-02       Impact factor: 3.441

6.  Increased susceptibility of beta7-integrin-deficient neonatal mice in the early stage of Cryptosporidium parvum infection.

Authors:  Roselyne Mancassola; Sonia Lacroix-Lamandé; Mathieu Barrier; Muriel Naciri; Henri Salmon; Fabrice Laurent
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

Review 7.  Drug Development Against the Major Diarrhea-Causing Parasites of the Small Intestine, Cryptosporidium and Giardia.

Authors:  Yukiko Miyamoto; Lars Eckmann
Journal:  Front Microbiol       Date:  2015-11-19       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.